Source document or public record

FDA 510(k) K213348 — BOND MMR Antibody Panel

FDA 510(k) index record K213348. Device: BOND MMR Antibody Panel. Applicant as listed: Leica Biosystems Newcastle, Ltd.. Decision date: 2023-02-21.

OtherU.S. Food and Drug Administration (FDA)2023-02-21

Source

"device_name": "BOND MMR Antibody Panel"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K213348.

Device name: BOND MMR Antibody Panel. Applicant as listed: Leica Biosystems Newcastle, Ltd..

Decision date: 2023-02-21. Decision wording: Substantially Equivalent.

Product code: PZJ. Regulation: 21 CFR 864.1866. Medical specialty: Immunology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.